Previous Close | 0.8828 |
Open | 0.8800 |
Bid | 0.7651 x 1800 |
Ask | 0.8100 x 1000 |
Day's Range | 0.8000 - 0.8800 |
52 Week Range | 0.3990 - 3.4000 |
Volume | |
Avg. Volume | 199,080 |
Market Cap | 40.03M |
Beta (5Y Monthly) | 1.78 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.4200 |
Earnings Date | Feb 13, 2023 - Feb 17, 2023 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 4.17 |
Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company, today announced it has signed its second distribution agreement with a top five US medical device distributor for the marketing and distribution of its two cardiac monitoring solutions (CMS) designed for cardiologists' patient use - Bioflux® and BiotresTM.
Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company, announced today that Company CEO Waqaas Alsiddiq has been invited to present at the Healthcare IT Virtual Conference, presented by Maxim Group LLC and hosted by M-Vest, on Wednesday, January 25th, 2023 at 8:15 a.m.
Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company, announced it has signed an agreement with a leading group purchasing organization ("GPO") for national distribution of its cardiac monitoring solutions, Bioflux® and BiotresTM.